Publication:
Role of prothrombin complex concentrate in the severe trauma patient.

dc.contributor.authorEgea-Guerrero, Juan Jose
dc.contributor.authorQuintana-Diaz, Manuel
dc.date.accessioned2023-05-03T13:41:27Z
dc.date.available2023-05-03T13:41:27Z
dc.date.issued2022-11-02
dc.description.abstractTraumatic hemorrhagic shock causes an estimated annual loss of more than 75 million years of life globally, and mostly affects young people (1). It is a time-dependent process, in which prehospital and emergency interventions must be sufficient to prevent the lethal triad of hypothermia, acidosis, and coagulopathy (2), and to avoid trauma-induced coagulopathy (TIC). Both are key determinants of trauma-associated mortality, so early control is essential to improve prognosis and reduce this outcome (3). During hemorrhagic shock, special attention needs to be paid to hyperfibrinolysis and deficiency of coagulation factors. The latter may be deficient for various reasons, such as loss due to hemorrhage, dilution due to vigorous fluid resuscitation, or the activation of pathophysiological mechanisms in TIC that mediate dysfunctionTraumatic hemorrhagic shock causes an estimated annual loss of more than 75 million years of life globally, and mostly affects young people (1). It is a time-dependent process, in which prehospital and emergency interventions must be sufficient to prevent the lethal triad of hypothermia, acidosis, and coagulopathy (2), and to avoid trauma-induced coagulopathy (TIC). Both are key determinants of trauma-associated mortality, so early control is essential to improve prognosis and reduce this outcome (3). During hemorrhagic shock, special attention needs to be paid to hyperfibrinolysis and deficiency of coagulation factors. The latter may be deficient for various reasons, such as loss due to hemorrhage, dilution due to vigorous fluid resuscitation, or the activation of pathophysiological mechanisms in TIC that mediate dysfunction
dc.description.versionSi
dc.identifier.citationEgea-Guerrero JJ, Quintana-Diaz M. Role of prothrombin complex concentrate in the severe trauma patient. Front Med (Lausanne). 2022 Nov 2;9:988919.
dc.identifier.doi10.3389/fmed.2022.988919
dc.identifier.issn2296-858X
dc.identifier.pmcPMC9666687
dc.identifier.pmid36405577
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666687/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fmed.2022.988919/pdf
dc.identifier.urihttp://hdl.handle.net/10668/20611
dc.journal.titleFrontiers in medicine
dc.journal.titleabbreviationFront Med (Lausanne)
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.page.number4
dc.provenanceRealizada la curación de contenido 09/07/2025.
dc.publisherFrontiers Research Foundation
dc.pubmedtypeJournal Article
dc.relation.publisherversionhttps://doi.org/10.3389/fmed.2022.988919
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectbleeding management protocol
dc.subjectcoagulation
dc.subjectmassive bleeding
dc.subjectprothrombin
dc.subjecttrauma-induced coagulopathy
dc.subject.decsResucitación
dc.subject.decsChoque hemorrágico
dc.subject.decsFactores de coagulación sanguínea
dc.subject.decsTrastornos de la coagulación sanguínea heredados
dc.subject.decsHipotermia inducida
dc.subject.decsHemofilia A
dc.subject.meshShock, Hemorrhagic
dc.subject.meshHypothermia
dc.subject.meshHemorrhage
dc.subject.meshBlood Coagulation Disorders
dc.subject.meshShock, Traumatic
dc.subject.meshBlood Coagulation Factors
dc.titleRole of prothrombin complex concentrate in the severe trauma patient.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number9
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9666687.pdf
Size:
917.35 KB
Format:
Adobe Portable Document Format